Status
Conditions
Treatments
About
This study aimed to assess the systemic absorption and disposition of tobramycin in patients treated with a tobramycin-laden bone graft substitute (Osteoset® T).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
12 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal